$AFJK·8-K

Aimei Health Technology Co., Ltd. · Jun 4, 4:05 PM ET

Compare

Aimei Health Technology Co., Ltd. 8-K

Research Summary

AI-generated summary

Updated

Aimei Health Extends SPAC Termination Date, Issues $34.33K Promissory Note

What Happened

  • Aimei Health Technology Co., Ltd. filed an 8‑K (June 4, 2026) announcing a one‑month extension of its SPAC termination date from June 6, 2026 to July 6, 2026. A total of $34,330.96 (the “Extension Payment”) was deposited into the company’s public shareholders’ trust account to effect the extension — the nineteenth extension permitted under the company’s current Amended and Restated Articles of Association.
  • To fund that Extension Payment, the company issued an unsecured promissory note dated June 4, 2026, in the principal amount of $34,330.96 to Aimei Health Ltd (the Sponsor) and United Hydrogen Group Inc. (together, the Payees).

Key Details

  • Extension amount deposited: $34,330.96 (represents the lesser of $80,000 total or $0.033 per outstanding public share per monthly extension).
  • New Termination Date: July 6, 2026 (extension from June 6, 2026).
  • Promissory Note: $34,330.96 principal, split equally ($17,165.48) to each Payee; unsecured, non‑interest bearing; principal due when the business combination with United Hydrogen closes.
  • Conversion right: Payees may (but are not required to) convert the note, in whole or part, into private units at $10.00 per unit (each unit = one ordinary share plus a right to 1/5 of an ordinary share) by giving at least two business days’ written notice before closing.

Why It Matters

  • The filing extends the deadline for Aimei Health to complete its initial business combination, giving the SPAC one more month to close a deal. Repeated extensions indicate the company has repeatedly delayed finalizing a business combination.
  • The promissory note creates a direct financial obligation that becomes due at closing; it is small in dollar terms but could convert into private units, which would dilute existing shareholders if conversion occurs.
  • The note is unsecured and non‑interest bearing and gives the Sponsor and United Hydrogen optional conversion rights, so investors should monitor future filings for any conversion, repayment, or further extensions.